KLEA HOLDING(EPA:ALKLH) stock Fundamental Analysis

Fundamental Rating

ALKLH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 53 industry peers in the Health Care Equipment & Supplies industry. While ALKLH is still in line with the averages on profitability rating, there are concerns on its financial health. ALKLH is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALKLH had negative earnings in the past year.

ALKLH had a positive operating cash flow in the past year.

In the past 5 years ALKLH reported 4 times negative net income.

ALKLH had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

ALKLH has a better Return On Assets (4.52%) than 69.81% of its industry peers.

The Return On Equity of ALKLH (6.26%) is better than 60.38% of its industry peers.

The Return On Invested Capital of ALKLH (2.49%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	4.52%
ROE	6.26%
ROIC	2.49%

ROA(3y)-7.42%

ROA(5y)-54.54%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALKLH has a better Profit Margin (10.78%) than 77.36% of its industry peers.

The Operating Margin of ALKLH (6.26%) is comparable to the rest of the industry.

The Gross Margin of ALKLH (94.89%) is better than 94.34% of its industry peers.

In the last couple of years the Gross Margin of ALKLH has grown nicely.

		Industry Rank	Sector Rank
OM	6.26%
PM (TTM)	10.78%
GM	94.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y115.58%

GM growth 5Y16.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALKLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

ALKLH has about the same amout of shares outstanding than it did 1 year ago.

ALKLH has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALKLH has a worse debt to assets ratio.

2.2 Solvency

ALKLH has an Altman-Z score of 3.38. This indicates that ALKLH is financially healthy and has little risk of bankruptcy at the moment.

ALKLH has a Altman-Z score of 3.38. This is in the better half of the industry: ALKLH outperforms 71.70% of its industry peers.

The Debt to FCF ratio of ALKLH is 19.51, which is on the high side as it means it would take ALKLH, 19.51 years of fcf income to pay off all of its debts.

ALKLH has a Debt to FCF ratio (19.51) which is in line with its industry peers.

ALKLH has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.

ALKLH's Debt to Equity ratio of 0.01 is amongst the best of the industry. ALKLH outperforms 98.11% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	19.51
Altman-Z	3.38

ROIC/WACC0.33

WACC7.6%

2.3 Liquidity

A Current Ratio of 0.60 indicates that ALKLH may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.60, ALKLH is doing worse than 83.02% of the companies in the same industry.

A Quick Ratio of 0.60 indicates that ALKLH may have some problems paying its short term obligations.

ALKLH has a Quick ratio of 0.60. This is in the lower half of the industry: ALKLH underperforms 79.25% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.6
Quick Ratio	0.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALKLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.68%, which is quite impressive.

ALKLH shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.05%.

The Revenue has been growing by 9.42% on average over the past years. This is quite good.

EPS 1Y (TTM)101.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%108.7%

Revenue 1Y (TTM)26.05%

Revenue growth 3Y-10.28%

Revenue growth 5Y9.42%

Sales Q2Q%23.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to grow by 23.35% on average over the next years. This is a very strong growth

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year33.08%

Revenue Next 2Y27.7%

Revenue Next 3Y23.35%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Forward Earnings ratio of 17.53, the valuation of ALKLH can be described as rather expensive.

Based on the Price/Forward Earnings ratio, ALKLH is valued a bit cheaper than the industry average as 66.04% of the companies are valued more expensively.

ALKLH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.42, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	17.53

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALKLH is valued a bit cheaper than 71.70% of the companies in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALKLH is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	202.69
EV/EBITDA	16.64

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALKLH does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KLEA HOLDING

EPA:ALKLH (5/8/2025, 7:00:00 PM)

0.1806

+0 (+0.06%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)07-29 2024-07-29

Earnings (Next)N/A N/A

Inst Owners1.26%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap55.54M

Analysts86.67

Price Target0.51 (182.39%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-28.57%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-5.46%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	17.53
P/S	3.66
P/FCF	202.69
P/OCF	22.71
P/B	2.12
P/tB	50.95
EV/EBITDA	16.64

EPS(TTM)0

EYN/A

EPS(NY)0.01

Fwd EY5.7%

FCF(TTM)0

FCFY0.49%

OCF(TTM)0.01

OCFY4.4%

SpS0.05

BVpS0.09

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.52%
ROE	6.26%
ROCE	3.39%
ROIC	2.49%
ROICexc	2.77%
ROICexgc	413.17%
OM	6.26%
PM (TTM)	10.78%
GM	94.89%
FCFM	1.8%

ROA(3y)-7.42%

ROA(5y)-54.54%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y115.58%

GM growth 5Y16.29%

F-Score7

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	19.51
Debt/EBITDA	0.11
Cap/Depr	85.41%
Cap/Sales	14.3%
Interest Coverage	250
Cash Conversion	70.02%
Profit Quality	16.75%
Current Ratio	0.6
Quick Ratio	0.6
Altman-Z	3.38

F-Score7

WACC7.6%

ROIC/WACC0.33

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)19.98%

Cap/Sales(5y)12.36%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)101.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%108.7%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)26.05%

Revenue growth 3Y-10.28%

Revenue growth 5Y9.42%

Sales Q2Q%23.13%

Revenue Next Year33.08%

Revenue Next 2Y27.7%

Revenue Next 3Y23.35%

Revenue Next 5YN/A

EBIT growth 1Y131.41%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year2550%

EBIT Next 3Y281.44%

EBIT Next 5YN/A

FCF growth 1Y116.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y623.37%

OCF growth 3YN/A

OCF growth 5YN/A

KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens